Carbon ion therapy (C12) for high-grade malignant salivary gland tumors (MSGTs) of the head and neck: do non-ACCs profit from dose escalation?

Overview of attention for article published in Radiation Oncology, July 2016

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 1,256 followers.

Carbon ion therapy (C12) for high-grade malignant salivary gland tumors (MSGTs) of the head and neck: do non-ACCs pr…https://t.co/3bIEaiEzvG

Radiat Oncol: "Carbon ion therapy (C12) for high-grade malignant salivary gland tumors (MSGTs) of the head and nec… https://t.co/OfwZgYn5ay